This is the authors' abstract. We don't add key points for this paper.
Neoadjuvant treatment is associated with improved OS and PFS in patients with BR-PDAC; however, this effect is outweighed by margin status. These results suggest that the primary benefit of NT was dependent on facilitating R0 resection. Upfront resection might remain a valid treatment option if R0 resection could be accurately predicted.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: